News Category: Press Release
-
Scripps Research chemist Benjamin Cravatt elected to American Philosophical Society
NULL
-
Scripps Research ranks third in 2026 Cure Innovation Index
NULL
-
Jin-Quan Yu elected to the National Academy of Sciences
Yu is recognized for his pioneering work in synthetic organic chemistry.
-
How a chemical reaction triggers brain inflammation in Alzheimer’s disease
Scripps Research scientists discovered that a chemically modified protein puts the brain’s immune cells in a state of damaging, chronic overactivation—and that blocking it protects brain cell connections.
-
Improving vaccine design for Ebola, HIV and more
Scripps Research scientists and colleagues develop a nanodisc platform that offers a clearer view of how key viral proteins interact with antibodies.
-
NIH expected to award Scripps Research nearly $4.2 million over 5 years to advance tools for vaccine design
Funding will expand methods for studying viral proteins and immune responses in more realistic settings for HIV and other severe pathogens.
-
New technique for synthesizing branched molecules could accelerate the development of future medicines
Scripps Research chemists solve a longstanding problem in the construction of branched molecular frameworks, unlocking a faster path to the complex structures found in drugs and materials.
-
Scripps Research’s Skaggs Graduate School ranked #1 in Biological Sciences by U.S. News & World Report
The doctoral program also placed #7 in Chemistry in the publication’s latest issue ranking top science graduate schools.
-
Scripps Research scientists uncover new mechanism cancer cells use to survive DNA damage
Discovery reshapes understanding of how tumor cells repair broken DNA, pointing toward more precise cancer therapies.
-
Study shows new drug compounds dial down inflammation without compromising immunity
First-in-class molecules block a specific protein interaction in immune cells, offering a potential targeted approach to autoimmune diseases like lupus and rheumatoid arthritis.